Serial entrepreneur, CEO, and private investor with 20+ years in pharma, biotech, and healthtech. As CEO of STADA AG (€2.5bn revenues), drove strategic repositioning and more than doubled the share price, culminating in a €5.3bn take-over by Bain Capital and Cinven. Co-founded and invested in multiple healthtech and deeptech ventures, delivering successful exits at 3–3.5x EV multiples. Currently CEO of BioCopy, pioneering AI-driven cancer biotherapeutics targeting intracellular cancer targets. Qualified lawyer with a PhD in corporate law, combining legal and commercial expertise across M&A, strategy, and corporate finance. Strong ties to PE, VC, and strategic investors across Europe.